DrugDec 5, 2018
ALLERGAN INFed recall — FDA D-0282-2019
Failed Stability Specification: out of specification for iron content.
Class IIFDA: TerminatedALLERGAN
Recall history in this database
Classification mix: Class II: 3, Class III: 1.
DrugMar 7, 2018
ALLERGAN INFeD recall — FDA D-0545-2018
Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.
Class IIFDA: TerminatedALLERGAN
DrugFeb 21, 2018
ALLERGAN NORCO recall — FDA D-0413-2018
Labeling: Not Elsewhere Classified: does not have the required "CII" controlled drug classification indication on the primary label.
Class IIIFDA: TerminatedALLERGAN
DrugJan 17, 2018
ALLERGAN Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle recall — FDA D-0154-2018
Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.
Class IIFDA: TerminatedALLERGAN
Understanding this recall history
This page summarizes recall records in which the official source identifies ALLERGAN as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.